Bristol-Myers Squibb Co
XETRA:BRM
Wall Street
Price Targets
BRM Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for
BRM
is 48.84 EUR
with a low forecast of 28.13 EUR and a high forecast of 60.07 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BRM's stock price target?
Price Target
48.84
EUR
According to Wall Street analysts, the average 1-year price target for
BRM
is 48.84 EUR
with a low forecast of 28.13 EUR and a high forecast of 60.07 EUR.
What is Bristol-Myers Squibb Co's Revenue forecast?
Projected CAGR
-5%
For the last 14 years the
compound annual growth rate for
Bristol-Myers Squibb Co's revenue is
6%.
The projected
CAGR
for the next 3 years is
-5%.
What is Bristol-Myers Squibb Co's Operating Income forecast?
Projected CAGR
-6%
For the last 14 years the
compound annual growth rate for
Bristol-Myers Squibb Co's operating income is
7%.
The projected
CAGR
for the next 3 years is
-6%.
What is Bristol-Myers Squibb Co's Net Income forecast?
Projected CAGR
17%
For the last 14 years the
compound annual growth rate for
Bristol-Myers Squibb Co's net income is
5%.
The projected
CAGR
for the next 3 years is
17%.
